J. Yamamoto et al., Effect of cisplatin on cell death and DNA crosslinking in rat mammary adenocarcinoma in vitro, ACT MED OKA, 53(5), 1999, pp. 201-208
The pharmacodynamic effects of cis-diamminedichloroplatinum(II) (CDDP) in v
itro have been reported, but the dosage and exposure time in vitro have not
been based on clinical observations of the drug's actions in vivo. In this
study, the authors attempted to evaluate the pharmacodynamic effects of CD
DP in vitro in terms of cell survival and DNA crosslinking by simulating un
bound CDDP administration at varying concentrations to a rat mammary adenoc
arcinoma line (known as line 66). CDDP exposure was conducted by both const
ant concentration procedures and a simulated in vivo procedure. Colony form
ation assay for the surviving fraction and alkaline elution assay for DNA c
rosslink measurement were performed in order to evaluate the pharmacodynami
cs of CDDP. Cell survival was a function of the area under the drug concent
ration time curve (AUC) of unbound CDDP (R-2 = 0.77, P < 0.002) for all dru
g exposure procedures as analyzed by the analysis of covariance test. There
was a strong correlation between the surviving fraction and the crosslink
index of the total amount of DNA crosslinks (R-2 = 0.85, P < 0.0005), Both
the total amount of DMA-DNA crosslinks and the DNA-protein crosslinks, of w
hich the latter were dominant, were affected not by the exposure procedures
, but by the AUC value (P < 0.002). The thresholds of cytocidal effect were
1.59 mg.h/l for the AUC and 0.008 for the crosslink index. The pharmacodyn
amic effects in vitro by simulated in vivo exposure were identical to those
of constant.